The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane-induced arthritis

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7894-7903

  Brenner, Max ^a   Meng, Hsiang Chi ^a   Yarlett, Nuriza C ^a   Joe, Bina ^b,e   Griffiths, Marie M ^c   Remmers, Elaine F ^b   Wilder, Ronald L ^b,f   Gulko, Pércio S ^a,d  

^a North Shore Long Island Jewish ^*  (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

^f MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 2; COMPLEMENTARY DNA; INTERLEUKIN 1BETA; MESSENGER RNA; PRISTANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; CHROMOSOME 10; CHROMOSOME 17Q; CHROMOSOME 5Q; CIA5 GENE; CIA5A GENE; CIA5D GENE; CONGENIC STRAIN; DISEASE SEVERITY; DNA SYNTHESIS; FEMALE; GENE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; MALE; NONHUMAN; PANNUS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIUM;

EID: 20444426895     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7894     Document Type: Article

References (69)

1. Seldin, M. F., C. I. Amos, R. Ward, and P. K. Gregersen. 1999. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 42: 1071-1079.
2. MacGregor, A. J., H. Snieder, A. S. Rigby, M. Koskenvuo, J. Kaprio, K. Aho, and A. J. Silman. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43: 30-37.
3. Osorio, Y. F. J., H. Bukulmez, E. Petit-Teixeira, L. Michou, C. Pierlot, S. Cailleau-Moindrault, I. Lemaire, S. Lasbleiz, O. Alibert, P. Quillet, et al. 2004. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum. 50: 2757-2765.
4. Jawaheer, D., M. F. Seldin, C. I. Amos, W. V. Chen, R. Shigeta, J. Monteiro, M. Kern, L. A. Criswell, S. Albani, J. L. Nelson, et al. 2001. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68: 927-936.
5. Jawaheer, D., M. F. Seldin, C. I. Amos, W. V. Chen, R. Shigeta, C. Etzel, A. Damle, X. Xiao, D. Chen, R. F. Lum, et al. 2003. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48: 906-916.
6. Comelis, F., S. Faure, M. Martinez, J. F. Prud'homme, P. Fritz, C. Dib, H. Alves, P. Barrera, N. de Vries, A. Balsa, et al. 1998. New susceptibility locus for rheumatoid arthritis suggested by a genome- wide linkage study. Proc. Natl. Acad. Sci. USA 95: 10746-10750.
7. Shiozawa, S., S. Hayashi, Y. Tsukamoto, H. Goko, H. Kawasaki, T. Wada, K. Shimizu, N. Yasuda, N. Kamatani, K. Takasugi, et al. 1998. Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10: 1891-1895.
8. MacKay, K., S. Eyre, A. Myerscough, A. Milicic, A. Barton, S. Laval, J. Barrett, D. Lee, S. White, S. John, et al. 2002. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. [Published erratum in appears in 2002 Arthritis Rheum. 46: 1406.] Arthritis Rheum. 46: 632-639.
9. Suzuki, A., R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, M. Suzuki, M. Nagasaki, M. Nakayama-Hamada, R. Kawaida, M. Ono, et al. 2003. Functional haplotypes of PAD14, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34: 395-402.
10. Okamoto, K., S. Makino, Y. Yoshikawa, A. Takaki, Y. Nagatsuka, M. Ota, G. Tamiya, A. Kimura, S. Bahram, and H. Inoko. 2003. Identification of IκBL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am. J. Hum. Genet. 72: 303-312.
11. Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35: 341-348.
12. Begovich, A. B., V. E. Carlton, L. A. Honigberg, S. J. Schrodi, A. P. Chokkalingam, H. C. Alexander, K. G. Ardlie, Q. Huang, A. M. Smith, J. M. Spoerke, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337.
13. Cantagrel, A., F. Navaux, P. Loubet-Lescoulie, F. Nourhashemi, G. Enault, M. Abbal, A. Constantin, M. Laroche, and B. Mazieres. 1999. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42: 1093-1100.
14. Buchs, N., T. Silvestri, F. S. di Giovine, M. Chabaud, E. Vannier, G. W. Duff, and P. Miossec. 2000. IL-4 VNTR gene polymorphism in chronic polyarthritis: the rare allele is associated with protection against destruction. Rheumatology 39: 1126-1131.
15. Gulko, P. S., and R. J. Winchester. 2001. Rheumatoid arthritis. In Samler's Immunologic Diseases, Vol. II. K. F. Austen, M. M. Frank, J. P. Atkinson, and H. Cantor, eds. Lippincott, Williams & Wilkins, Baltimore, p. 427-463.
16. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247.
17. Lander, E., and N. Schork. 1994. Genetic dissection of complex traits. [Published erratum in appears in 1994 Science 266: 353.] Science 265: 2037-2048.
18. Jacob, H. J. 1999. Functional genomics and rat models. Genome Res. 9: 1013-1016.
19. Gulko, P. S., Y. Kawahito, E. F. Remmers, V. R. Reese, J. Wang, S. V. Dracheva, L. Ge, R. E. Longman, J. S. Shepard, G. W. Cannon, et al. 1998. Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen- induced arthritis in rats. Arthritis Rheum. 41: 2122-2131.
20. Remmers, E. F., R. E. Longman, Y. Du, A. O'Hare, G. W. Cannon, M. M. Griffiths, and R. L. Wilder. 1996. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat. Genet. 14: 82-85.
21. Kawahito, Y., G. Cannon, P. Gulko, E. Remmers, R. Longman, V. Reese, J. Wang, M. Griffiths, and R. Wilder. 1998. Localization of quantitative trait loci regulating adjuvant induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. J. Immunol. 161: 4411-4419.
22. Dracheva, S. V., E. F. Remmers, P. S. Gulko, Y. Kawahito, R. E. Longman. V. R. Reese, G. W. Cannon, M. M. Griffiths, and R. L. Wilder. 1999. Identification of a new quantitative trait locus on chromosome 7 controlling disease severity of collagen-induced arthritis in rats. Immunogenetics 49: 787-791.
23. Vingsbo-Lundberg, C., N. Nordquist, P. Olofsson, M. Sundvall, T. Saxne, U. Pettersson, and R. Holmdahl. 1998. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat. Genet. 20: 401-404.
24. Bergsteinsdottir, K., H. T. Yang, U. Pettersson, and R. Holmdahl. 2000. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J. Immunol. 164: 1564-1568.
25. Olofsson, P., S. Lu, J. Holmberg, T. Song, P. Wernhoff, U. Pettersson, and R. Holmdahl. 2003. A comparative genetic analysis between collagen-induced arthritis and pristane-induced arthritis. Arthritis Rheum. 48: 2332-2342.
26. Lorentzen, J. C., A. Glaser, L. Jacobsson, J. Galli, H. Fakhrai-rad, L. Klareskog, and H. Luthman. 1998. Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc. Natl. Acad. Sci. USA 95: 6383-6387.
27. Griffiths, M. M., J. Wang, B. Joe, S. Dracheva, Y. Kawahito, J. S. Shepard, V. R. Reese, S. McCall-Vining, A. Hashiramoto, G. W. Cannon, et al. 2000. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis. Arthritis Rheum. 43: 1278-1289.
28. Furuya, T., J. L. Salstrom, S. McCall-Vining, G. W. Cannon, B. Joe, E. F. Remmers, M. M. Griffiths, and R. L. Wilder. 2000. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci. Hum. Mol. Genet. 9: 2241-2250.
29. Wester, L., P. Olofsson, S. M. Ibrahim, and R. Holmdahl. 2003. Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14. J. Autoimmun. 21: 305-313.
30. Meng, H. C., M. M. Griffiths, E. F. Remmers, Y. Kawahito, W. Li, R. Neisa, G. W. Cannon, R. L. Wilder, and P. S. Gulko. 2004. Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum. 50: 2695-2705.
31. Wemhoff, P., P. Olofsson, and R. Holmdahl. 2003. The genetic control of rheumatoid factor production in a rat model of rheumatoid arthritis. Arthritis Rheum. 48: 3584-3596.
32. Joe, B., E. F. Remmers, D. E. Dobbins, J. L. Salstrom, T. Furuya, S. Dracheva, P. S. Gulko, G. W. Cannon, M. M. Griffiths, and R. L. Wilder. 2000. Genetic dissection of collagen-induced arthritis in chromosome 10 quantitative trait locus speed congenic rats: evidence for more than one regulatory locus and sex influences. Immunogenetics 51: 930-944.
33. Remmers, E. F., B. Joe, M. M. Griffiths, D. E. Dobbins, S. V. Dracheva, A. Hashiramoto, T. Furuya, J. L. Salstrom, J. Wang, P. S. Gulko, et al. 2002. Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum. 46: 2225-2234.
34. Joe, B., G. W. Cannon, M. M. Griffiths, D. E. Dobbins, P. S. Gulko, R. L. Wilder, and E. F. Remmers. 2002. Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocongenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis susceptibility loci. Arthritis Rheum. 46: 1075-1085.
35. Jagodic, M., B. Kornek, R. Weissert, H. Lassmann, T. Olsson, and I. Dahlman. 2001. Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Immunogenetics 53: 410-415.
36. Roth, M. P., C. Viratelle, L. Dolbois, M. Delverdier, N. Borot, L. Pelletier, P. Druet, M. Clanet, and H. Coppin. 1999. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J. Immunol. 162: 1917-1922.
37. Sun, S. H., P. B. Silver, R. R. Caspi, Y. Du, C. C. Chan, R. L. Wilder, and E. F. Remmers. 1999. Identification of genomic regions controlling experimental autoimmune uveoretinitis in rats. Int. Immunol 11: 529-534.
38. Barton, A., S. Eyre, A. Myerscough, B. Brintnell, D. Ward, W. E. Ollier, J. C. Lorentzen, L. Klareskog, A. Silman, S. John, and J. Worthington. 2001. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Hum. Mol. Genet. 10: 1901-1906.
39. Vingsbo, C., P. Sahlstrand, J. Bran, R. Jonsson, T. Saxne, and R. Holmdahl. 1996. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149: 1675-1683.
40. Wilder, R., E. Remmers, Y. Kawahito, P. Gulko, G. Cannon, and M. Griffiths. 1999. Genetic factors regulating experimental arthritis in mice and rats. In Current Directions in Autoimmunity, Vol. 1. A. Theophilopoulos, ed. Karger, Basel, p. 121-165.
41. Brenner, M., H. Meng, N. C. Yarlett, M. M. Griffiths, E. F. Remmers, R. L. Wilder, and P. S. Gulko. 2005. The non-MHC quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation and joint damage. Arthritis Rheum. 52: 322-332.
42. T) method. Methods 25: 402-408.
43. Edwards, J. C., L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, and T. Shaw. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581.
44. Kremer, J. M., R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349: 1907-1915.
45. Lipsky, P. E., D. M. van der Heijde, E. W. St Clair, D. E. Furst, F. C. Breedveld, J. R. Kalden, J. S. Smolen, M. Weisman, P. Emery, M. Feldmann, et al. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med. 343: 1594-1602.
46. Weinblatt, M. E., J. M. Kremer, A. D. Bankhurst, K. J. Bulpitt, R. M. Fleischmann, R. I. Fox, C. G. Jackson, M. Lange, and D. J. Burge. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340: 253-259.
47. 3 antagonist. J. Clin. Invest. 103: 47-54.
48. Sone, H., Y. Kawakami, M. Sakauchi, Y. Nakamura, A. Takahashi, H. Shimano, Y. Okuda, T. Segawa, H. Suzuki, and N. Yamada. 2001. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem. Biophys. Res. Commun. 281: 562-568.
49. Kleinau, S., H. Erlandsson, R. Holmdahl, and L. Klareskog. 1991. Adjuvant oils induce arthritis in the DA rat. 1. Characterization of the disease and evidence for an immunological involvement. J. Autoimmun. 4: 871-880.
50. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95: 13859-13864.
51. Fava, R. A., N. J. Olsen, A. E. Postlethwaite, K. N. Broadley, J. M. Davidson, L. B. Nanney, C. Lucas, and A. S. Townes. 1991. Transforming growth factor β1 (TGF-β1) induced neutrophil recruitment to synovial tissues: implications for TGF-β-driven synovial inflammation and hyperplasia. J. Exp. Med. 173: 1121-1132.
52. Langdon, C., C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards. 2000. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am. J. Pathol. 157: 1187-1196.
53. Leung, B. P., I. B. McInnes, E. Esfandiari, X. Q. Wei, and F. Y. Liew. 2000. Combined effects of IL-12 and IL-18 on the induction of collagen- induced arthritis. J. Immunol. 164: 6495-6502.
54. Szekanecz, Z., G. Szegedi, and A. E. Koch. 1998. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J. Investig. Med. 46: 27-41.
55. Rioja, I., K. A. Bush, J. B. Buckton, M. C. Dickson, and P. F. Life. 2004. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin. Exp. Immunol. 137: 65-73.
56. Palmblad, K., H. Erlandsson-Harris, K. J. Tracey, and U. Andersson. 2001. Dynamics of early synovial cytokine expression in rodent collagen- induced arthritis: a therapeutic study using a macrophage-deactivating compound. Am. J. Pathol. 158: 491-500.
57. Olofsson, P., J. Holmberg, U. Pettersson, and R. Holmdahl. 2003. Identification and isolation of dominant susceptibility loci for pristane-induced arthritis. J. Immunol. 171: 407-416.
58. Holm, B. C., H. Wei Xu, L. Jacobsson, A. Larsson, H. Luthman, and J. C. Lorenlzen. 2001. Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis. Hum. Mol. Genet. 10: 565-572.
59. Quo, J. M., R. Chandrasekeran, C. Vermes, K. Mikecz, A. Finnegan, S. E. Ricken, J. T. Enders, and T. T. Giant. 2000. A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J. Immunol. 165: 5278-5286.
60. Dahlman, I., E. Wallstrom, R. Weissert, M. Storch, B. Kornek, L. Jacobsson, C. Linington, H. Luthman, H. Lassmann, and T. Olsson. 1999. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 8: 2183-2190.
61. Listwak, S., R. M. Barrientos, G. Koike, S. Ghosh, M. Gomez, B. Misiewicz, and E. M. Sternberg. 1999. Identification of a novel inflammation-protective locus in the Fischer rat. Mamm. Genome 10: 362-365.
62. Kermarrec, N., C. Dubay, B. De Gouyon, C. Blanpied, D. Gauguier, K. Gillespie, P. W. Mathieson, P. Druet, M. Lathrop, and F. Hirsch. 1996. Serum IgE concentration and other immune manifestations of treatment with gold salts are linked to the MHC and IL4 regions in the rat. Genomics 31: 111-114.
63. Sawcer, S., H. B. Jones, R. Feakes, J. Gray, N. Smaldon, J. Chataway, N. Robertson, D. Clayton, P. N. Goodfellow, and A. Compston. 1996. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13: 464-468.
64. Tomfohrde, J., A. Silverman, R. Barnes, M. A. Fernandez-Vina, M. Young, D. Lory, L. Morris, K. D. Wuepper, P. Stastny, A. Menter, et al. 1994. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome I7q. Science 264: 1141-1145.
65. Sakai, K., S. Shirasawa, N. Ishikawa, K. Ito, H. Tamai, K. Kuma, T. Akamizu, M. Tanimura, K. Furugaki, K. Yamamoto, and T. Sasazuki. 2001. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint aifected sib-pair linkage analysis in Japanese. Hum. Mol. Genet. 10: 1379-1386.
66. Rioux, J. D., M. J. Daly, M. S. Silverberg, K. Lindblad, H. Steinhart, Z. Cohen, T. Delmonte, K. Kocher, K. Miller, S. Guschwan, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29: 223-238.
67. Becker, K. G., R. M. Simon, J. E. Bailey-Wilson, B. Freidlin, W. E. Biddison, H. F. McFarland, and J. M. Trent. 1998. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95: 9979-9984.
68. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
69. Bottini, N., L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M. Rostamkhani, J. MacMurray, G. F. Meloni, P. Lucarelli, M. Pellecchia, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338.